Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells

Boris Calmels, Cole Ferguson, Mikko O. Laukkanen, Rima Adler, Marion Faulhaber, Hyeoung Joon Kim, Stephanie Sellers, Peiman Hematti, Manfred Schmidt, Christof Von Kalle, Keiko Akagi, Robert E. Donahue, Cynthia E. Dunbar

Research output: Contribution to journalArticlepeer-review

136 Scopus citations


Recent reports linking insertional activation of LMO2 following gene therapy for X-linked severe combined immunodeficiency (X-SCID) have led to a re-evaluation of risks following gene therapy with retroviral vectors. In our analysis of 702 integration sites in rhesus macaques that underwent transplantation up to 7 years earlier with autologous CD34+ cells transduced with amphotropic murine leukemia virus (MLV)-derived retroviral vectors containing marker genes, we detected insertion into one locus, the Mds1/Evi1 region, a total of 14 times in 9 animals. Mds1/Evi1 integrations were observed stably long term, primarily in myeloid cells. We hypothesize that this over-representation likely results from an impact on the self-renewal and engraftment potential of CD34+ progenitor cells via insertional mutagenesis at this specific locus. There is no evidence of ongoing in vivo clonal expansion of the Mds1/Evi1 populations, and all animals are hematologically normal without evidence for leukemia. Characterization of integration sites in this relevant preclinical model provides critical information for gene therapy risk assessment as well as identification of genes controlling hematopoiesis.

Original languageEnglish
Pages (from-to)2530-2533
Number of pages4
Issue number7
StatePublished - Oct 2005


Dive into the research topics of 'Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells'. Together they form a unique fingerprint.

Cite this